Skip to content
← Back to this collection

PUBLICATIONS · 20970380

High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2010 Nov
First author
Thiel E

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2010 Nov;11(11):1011-2. doi: 10.1016/S1470-2045(10)70234-5.
    note
    Source null
    related pmid
    20970379
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2011 Feb;12(2):118-9; author reply 119-20. doi: 10.1016/S1470-2045(11)70018-3.
    note
    Source null
    related pmid
    21277546
    relationship
    Comment in

Authors and identifiers

  1. name
    Thiel E
    type
    Author
  2. name
    Korfel A
    type
    Author
  3. name
    Martus P
    type
    Author
  4. name
    Kanz L
    type
    Author
  5. name
    Griesinger F
    type
    Author
  6. name
    Rauch M
    type
    Author
  7. name
    Röth A
    type
    Author
  8. name
    Hertenstein B
    type
    Author
  9. name
    von Toll T
    type
    Author
  10. name
    Hundsberger T
    type
    Author
  11. name
    Mergenthaler HG
    type
    Author
  12. name
    Leithäuser M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Thiel E
    type
    Author
  2. name
    Korfel A
    type
    Author
  3. name
    Martus P
    type
    Author
  4. name
    Kanz L
    type
    Author
  5. name
    Griesinger F
    type
    Author
  6. name
    Rauch M
    type
    Author
  7. name
    Röth A
    type
    Author
  8. name
    Hertenstein B
    type
    Author
  9. name
    von Toll T
    type
    Author
  10. name
    Hundsberger T
    type
    Author
  11. name
    Mergenthaler HG
    type
    Author
  12. name
    Leithäuser M
    type
    Author
bibliography ids
  1. nci-bib-c0079f520dc6db7759124d2b
book metadata
content sha256
2fc4d6816137172379fbf39819480a976cf0755ff18ad4fa3ae64cf30db32811
document type
citation
dois
  1. 10.1016/S1470-2045(10)70229-1
electronic publication date
display
2010 Oct 20
precision
day
year
2010
evidence scope
bibliographic_metadata_only
id
pubmed:20970380
immutable id
pubmed:20970380@2fc4d6816137172379fbf39819480a976cf0755ff18ad4fa3ae64cf30db32811
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
11
name
The Lancet. Oncology
nlm unique id
100957246
pages
1036-47
volume
11
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2010 Nov;11(11):1011-2. doi: 10.1016/S1470-2045(10)70234-5.
    note
    Source null
    related pmid
    20970379
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2011 Feb;12(2):118-9; author reply 119-20. doi: 10.1016/S1470-2045(11)70018-3.
    note
    Source null
    related pmid
    21277546
    relationship
    Comment in
outcomes validated
false
pmid
20970380
provenance
batch id
10a38257e12e9ed1867a
provider
NCBI PubMed ESummary
record sha256
0143f04e5d7edb2d28302deb742160c413409c64864f47a8c2874e7a8cba852f
response sha256
84c4808ca38b35d999cfdf809eb088835175ab38d71586c626096d677096bbcc
retrieved at
2026-09-09T23:46:35.793530+00:00
publication date
display
2010 Nov
precision
month
year
2010
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/20970380/
title
High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.

Preserved source evidence · Not medical advice